Authors:
CHANDRASEKAR PH
MOMIN F
KARANES C
ABELLA S
RATANATHARATHORN V
SENSENBRENNER L
Citation: Ph. Chandrasekar et al., DISSEMINATED TOXOPLASMOSIS IN MARROW RECIPIENTS - A REPORT OF 3 CASESAND A REVIEW OF THE LITERATURE, Bone marrow transplantation, 19(7), 1997, pp. 685-689
Authors:
VARTERASIAN M
RATANATHARATHORN V
UBERTI JP
KARANES C
ABELLA E
MOMIN F
KASTENSPORTES C
ALKATIB A
LUM L
HEILBRUN LK
SENSENBRENNER LL
Citation: M. Varterasian et al., CLINICAL COURSE AND OUTCOME OF PATIENTS WITH HODGKINS-DISEASE WHO PROGRESS AFTER AUTOLOGOUS TRANSPLANTATION, Leukemia & lymphoma, 20(1-2), 1995, pp. 59-65
Authors:
VARTERASIAN M
RATANATHARATHORN V
KARANES C
UBERTI J
MOMIN F
ABELLA E
LUM LG
HEILBRUN LK
SENSENBRENNER LL
Citation: M. Varterasian et al., BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA - THE WAYNE-STATE EXPERIENCE, Bone marrow transplantation, 15(2), 1995, pp. 328-329
Authors:
SHIBUYA TY
MOMIN F
ABELLA E
JACOBS JR
KARANES C
RATANATHARATHORN V
SENSENBRENNER LL
LUM LG
Citation: Ty. Shibuya et al., SINUS DISEASE IN THE BONE-MARROW TRANSPLANT POPULATION - INCIDENCE, RISK-FACTORS, AND COMPLICATIONS, Otolaryngology and head and neck surgery, 113(6), 1995, pp. 705-711
Authors:
TURKERI LN
LUM LG
UBERTI JP
ABELLA E
MOMIN F
KARANES C
SENSENBRENNER LL
HAAS GP
Citation: Ln. Turkeri et al., PREVENTION OF HEMORRHAGIC CYSTITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT PREPARATIVE REGIMENS WITH CYCLOPHOSPHAMIDE AND BUSULFAN - ROLE OF CONTINUOUS BLADDER IRRIGATION, The Journal of urology, 153(3), 1995, pp. 637-640
Citation: F. Momin et Ph. Chandrasekar, ANTIMICROBIAL PROPHYLAXIS IN BONE-MARROW TRANSPLANTATION, Annals of internal medicine, 123(3), 1995, pp. 205-215
Authors:
LUM L
BITONTI O
JIN NR
GALOFORO S
WALKER A
LUM C
ABELLA E
BABINGTON R
KARANES C
MOMIN F
UBERTI J
RATANATHARATHORN V
SENSENBRENNER L
Citation: L. Lum et al., INTRAVENOUS GAMMA-GLOBULIN (IVIG) DOES NOT ALTER IMMUNE PARAMETERS INA RANDOMIZED TRIAL AFTER BONE-MARROW TRANSPLANTATION (BMT), Experimental hematology, 22(8), 1994, pp. 680-680
Authors:
MOMIN F
RATNATHARATHORN V
UBERTI J
ABELLA E
KARANES C
CASE P
LUM L
SENSENBRENNER L
Citation: F. Momin et al., COMPARISON OF OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)USING HLA IDENTICAL SIBLING, MATCHED UNRELATED, AND RELATED HLA MISMATCHED DONORS, Experimental hematology, 22(8), 1994, pp. 715-715
Authors:
RATANATHARATHORN V
UBERTI J
KARANES C
ABELLA E
LUM LG
MOMIN F
CUMMINGS G
SENSENBRENNER LL
Citation: V. Ratanatharathorn et al., PROSPECTIVE COMPARATIVE TRIAL OF AUTOLOGOUS VERSUS ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Blood, 84(4), 1994, pp. 1050-1055
Authors:
RATANATHARATHORN V
KARANES C
MOMIN F
UBERTI JP
SENSENBRENNER LL
ABELLA E
LUM LG
Citation: V. Ratanatharathorn et al., PREPARATIVE REGIMES WITHOUT TOTAL-BODY IRRADIATION (TBI) IN THE RECIPIENTS OF UNRELATED DONOR MARROW, Blood, 84(10), 1994, pp. 10000342-10000342
Authors:
KARANES C
UBERTI JP
RATANATHARATHORN V
LUM L
ABELLA E
MOMIN F
SENSENBRENNER L
Citation: C. Karanes et al., CYCLOPHOSPHAMIDE, VP-16, AND BCNU (CVB) FOR AUTOLOGOUS AND ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT) IN NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000144-10000144
Authors:
UBERTI JP
KARANES C
RATANATHARATHORN V
LUM L
ABELLA E
MOMIN F
SENSENBRENNER L
Citation: Jp. Uberti et al., BUSULFAN-BASED PREPARATIVE REGIMENS FOR ACUTE MYELOID-LEUKEMIA IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - THE ROLE OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) FOR HIGH-RISK PATIENTS, Blood, 82(10), 1993, pp. 10000643-10000643